Delivery Order SPE2DB22D1103-SPE2DB25FH3P8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on August 29, 2025, with a ceiling value of $1,419.34 and completion deadline of September 2, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,323.16. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count supply) on September 18, 2025, with a ceiling value of $8,208.17 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,764.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count packaging) under a firm fixed-price contract valued at $1,014.56. This non-set-aside delivery order represents a small-value pharmaceutical procurement with a completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,914.97. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is set to be completed by July 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,320.87. This is a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The order is scheduled for ultimate completion on July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.50 to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3P8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a contract ceiling value of $2,430.44. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The pharmaceutical products will be delivered to the company's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor contract running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies medications, medical devices, and healthcare commodities to military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's portfolio of DLA awards demonstrates extensive capability in delivering a wide spectrum of pharmaceutical products across multiple therapeutic domains through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/29/25 |